Washington, DC (PRWEB) November 18, 2013
The award winning MDLinx content, http://www.mdlinx.com, is now offered as membership benefit to all PDR’s members. Through this tightly integrated partnership with PDR, http://www.pdrnetwork.com, M3 is now capable of reaching nearly 600,000 US physicians on behalf of its customers in brand marketing, market research, and physician recruiting.
“PDR is a one-of-a-kind brand, trusted by physicians to deliver highly relevant drug information,” remarked Aki Tomaru, CEO of M3 USA. “MDLinx has been the leading website for U.S. specialty physicians. With the launching of PDR Powered by MDLinx, http://www.mdlinx.pdr.net, M3 adds 330,000 US physicians, significantly extending our reach in key specialties such as primary care, psychiatry, urology and pediatrics. Combined with our existing industry leading coverage in oncology, rheumatology and endocrinology, our HCP reach may be the best to the specialties that matter most to both Pharmaceutical and Life Science companies. This represents a tremendous opportunity for our customers.”
“We are thrilled to partner with MDLinx, as PDR continues to expand our HCP offerings,” comments Rich Altus, President of PDR. “Their practical medical information can now be found right on our site, PDR Powered by MDLinx. This powerful offering will provide even more reasons for prescribers to rely on PDR for the most relevant drug and clinical information inside and outside of workflow.” PDR continues to lead the industry by providing drug information and patient support inside the physician’s Electronic Heal
Copyright©2012 Vocus, Inc.
All rights reserved